Artia Global Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,400	Closed	-$6.92M	–	52
2025 Q4	$6.92M	Sell	17,400 -17,170	-50%	-$7.6M	1.11%	19
2025 Q3	$15.8M	Buy	34,570 +13,600	+65%	+$5.54M	2.77%	14
2025 Q2	$6.84M	Sell	20,970 -7,630	-27%	-$2.11M	1.76%	13
2025 Q1	$7.72M	Sell	28,600 -27,800	-49%	-$7.14M	2.26%	14
2024 Q4	$13.3M	Buy	56,400 +21,400	+61%	+$5.63M	5.35%	9
2024 Q3	$9.63M	Hold	35,000	–	–	2.72%	8
2024 Q2	$8.51M	Buy	+35,000	New	+$5.53M	2.18%	10
2023 Q4	–	Sell	-15,971	Closed	-$2.83M	–	32
2023 Q3	$2.83M	Hold	15,971	–	–	1.18%	16
2023 Q2	$3.03M	Hold	15,971	–	–	1.05%	23
2023 Q1	$3.2M	Hold	15,971	–	–	1.29%	19
2022 Q4	$3.8M	Buy	+15,971	New	+$3.41M	1.46%	14